Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects
Clinical trial NCT06902090 · COMPLETED
Trial details
- NCT number
- NCT06902090
- Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2023-07-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.